Labopharm tapped Purdue Pharma today as US licensee and distributor for the analgesic tramadol. Labopharm expects to submit its new drug application for tramadol to the FDA later this year. The licensing deal nets Labopharm an upfront fee of $20 million plus $40 million on FDA approval; the total cash payments could reach $170 million, plus royalties of 20 percent to 25 percent.
- read this press release for more